Quantitative analysis of plasma circulating DNA at diagnosis and during follow-up of breast cancer patients

Cancer Letters

Volumn 243, Issue 1, 2006, Pages 64-70

  Huang, Zhao Hui ^a   Li, Li Hua ^a   Hua, Dong ^a  

^a SOOCHOW UNIVERSITY   (China)

Author keywords

Breast cancer; Circulating DNA; Plasma

Indexed keywords

DNA;

ADULT; ARTICLE; BREAST CANCER; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BREAST NEOPLASMS; DNA, NEOPLASM; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS;

EID: 33749260689     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2005.11.027     Document Type: Article

References (26)

1. Kattlove H., Liberati A., Keeler E., and Brook R. Benefits and costs of screening and treatment for early breast cancer. J. Am. Med. Assoc. 273 (1995) 142-148
2. Chen X., Bonnefoi H., Diebold-Berger S., Lyautey J., Lederrey C., Faltin-Traub E., et al. Detecting tumor-related alterations in plasma or serum DNA of patients diagnosed with breast cancer. Clin. Cancer Res. 5 (1999) 2297-2303
3. Leon S.A., Shapiro B., Sklaroff D.M., and Yaros M.J. Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res. 37 (1977) 646-650
4. Silva J.M., Dominguez G., Garcia J.M., Gonzalez R., Villanueva M.J., Navarro F., et al. Presence of tumor DNA in plasma of breast cancer patients: clinicopathological correlations. Cancer Res. 59 (1999) 3251-3256
5. Silva J.M., Garcia J.M., Dominguez G., Silva J., Miralles C., Cantos B., et al. Persistence of tumor DNA in plasma of breast cancer patients after mastectomy. Ann. Surg. Oncol. 9 (2002) 71-76
6. Sozzi G., Conte D., Mariani L., Lo Vullo S., Roz L., Lombardo C., et al. Analysis of circulating tumor DNA in plasma at diagnosis and during follow-up of lung cancer patients. Cancer Res. 61 (2001) 4675-4678
7. Jung K., Stephan C., Lewandowski M., Klotzek S., Jung M., and Kristiansen G. Increased cell-free DNA in plasma of patients with metastatic spread in prostate cancer. Cancer Lett. 205 (2004) 173-180
8. Chang H.W., Lee S.M., Goodman S.N., Singer G., Cho S.K., Sokoll L.J., et al. Assessment of plasma DNA levels, allelic imbalance, and CA 125 as diagnostic tests for cancer. J. Natl Cancer Inst. 94 (2002) 1697-1703
9. Sorenson G.D., Pribish D.M., Valone F.H., Memoli V.A., Bzik D.J., and Yao S.L. Soluble normal and mutated DNA sequences from single-copy genes in human blood. Cancer Epidemiol. Biomarkers Prev. 3 (1994) 67-71
10. Nawroz H., Koch W., Anker P., Stroun M., and Sidransky D. Microsatellite alterations in serum DNA of head and neck cancer patients. Nature Med. 2 (1996) 1035-1037
11. Wong B.C.K., and Lo Y.M.D. Cell-free DNA and RNA in plasma as new tools for molecular diagnostics. Expert Rev. Mol. Diagn. 3 (2003) 89-101
12. Gal S., Fidler C., Lo Y.M.D., Taylor M., Han C., Moore J., et al. Quantitation of circulating DNA in the serum of breast cancer patients by real-time PCR. Br. J. Cancer 90 (2004) 1211-1215
13. Leung T.N., Zhang J., Lau T.K., Chan L.Y., and Lo Y.M.D. Increased maternal plasma fetal DNA concentrations in women who eventually develop preeclampsia. Clin. Chem. 47 (2001) 137-139
14. Lo Y.M.D., Tein M.S.C., Lau T.K., Haines C.J., Leung T.N., Poon P.M.K., et al. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am. J. Hum. Genet. 62 (1998) 768-775
15. Chiu R.W.K., Poon L.L., Lau T.K., Leung T.N., Wong E.M., and Lo Y.M.D. Effects of blood-processing protocols on fetal and total DNA quantification in maternal plasma. Clin. Chem. 47 (2001) 1607-1613
16. Swinkels D.W., Wiegerinck E., Steegers E.A.P., and de Kok J.B. Effects of blood-processing protocols on cell-free DNA quantification in plasma. Clin. Chem. 49 (2003) 525-526
17. de Kok J.B., Hendriks J.C., van Solinge W.W., Willems H.L., Mensink E.J., and Swinkels D.W. Use of real-time quantitative PCR to compare DNA isolation methods. Clin. Chem. 44 (1998) 2201-2204
18. Lee T.H., Montalvo L., Chrebtow V., and Busch M.P. Quantitation of genomic DNA in plasma and serum samples: higher concentrations of genomic DNA found in serum than in plasma. Transfusion 41 (2001) 276-282
19. Lui Y.Y., Chik K.W., Chiu R.W., Ho C.Y., Lam C.W., and Lo Y.M. Predominant hematopoietic origin of cell-free DNA in plasma and serum after sex-mismatched bone marrow transplantation. Clin. Chem. 48 (2002) 421-427
20. Thijssen M.A., Swinkels D.W., Ruers T.J., and de Kok J.B. Difference between free circulating plasma and serum DNA inpatients with colorectal liver metastases. Anticancer Res. 22 (2002) 421-425
21. Herrera L.J., Raja S., Gooding W.E., El-Hefnawy T., Kelly L., Luketich J.D., and Godfrey T.E. Quantitative analysis of circulating plasma DNA as a tumor marker in thoracic malignancies. Clin. Chem. 51 (2005) 113-118
22. Fournie G.J., Courtin J.P., Laval F., Chale J.J., Pourrat J.P., Pujazon M.C., et al. Plasma DNA as a marker of cancerous cell death. Investigations in patients suffering from lung cancer and in nude mice bearing human tumours. Cancer Lett. 91 (1995) 221-227
23. Sozzi G., Conte D., Leon M., Ciricione R., Roz L., Ratcliffe C., et al. Quantification of free circulating DNA as a diagnostic marker in lung cancer. J. Clin. Oncol. 21 (2003) 3902-3908
24. Gautschi O., Bigosch C., Huegli B., Jermann M., Marx A., Chassé E., et al. Circulating deoxyribonucleic- acid as prognostic marker in non-small-cell lung cancer patients undergoing chemotherapy. J. Clin. Oncol. 22 (2004) 4157-4164
25. Wang B.G., Huang H.Y., Chen Y.C., Bristow R.E., Kassauei K., Cheng C.C., et al. Increased plasma DNA integrity in cancer patients. Cancer Res. 63 (2003) 3966-3968
26. Caponigro F. CA 153 in human breast cancer. Comparison with tissue polypeptide antigen (TPA) and carcinoembryonic antigen (CEA). Int. J. Biol. Markers 5 (1990) 73-76